0000896262-21-000027.txt : 20210219
0000896262-21-000027.hdr.sgml : 20210219
20210219161258
ACCESSION NUMBER: 0000896262-21-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210219
DATE AS OF CHANGE: 20210219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: North Michael Paul
CENTRAL INDEX KEY: 0001689925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 21655710
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY, SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_161376915268485.xml
FORM 4
X0306
4
2021-02-17
0
0000896262
AMEDISYS INC
AMED
0001689925
North Michael Paul
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
Chief Information Officer
Common Stock
2021-02-17
4
M
0
3396
0
A
7715
D
Common Stock
2021-02-17
4
F
0
331
295.20
D
7384
D
Common Stock
2021-02-17
4
A
0
636
0
A
8020
D
Common Stock
2021-02-17
4
A
0
3388
0
A
11408
D
Common Stock
457
I
Through 401(k) Plan
Restricted Share Units (Performance-Based Vesting)
2021-02-17
4
M
0
1698
0
D
Common Stock
1698.0
0
D
Stock Option (Right to Buy)
295.2
2021-02-17
4
A
0
1600
0
A
2031-02-17
Common Stock
1600.0
1600
D
Performance-Based Restricted Shares
2021-02-17
4
A
0
1271
0
A
Common Stock
1271.0
1271
D
On February 12, 2020, the Reporting Person was awarded performance-based Restricted Stock Units ("RSUs") with vesting provisions based on certification of achievement of an identified performance measure for 2020, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2022, 2023 and 2024, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported in a Form 4 filed on February 14, 2020 was 1,698 RSUs, which was the amount of shares payable at target performance; the Reporting Person was eligible to earn 50%-200% of the amount reported depending on the level of performance achieved. On February 17, 2021, the Compensation Committee of the Issuer's Board of Directors certified achievement of the 2020 performance measure at 200%, thereby resulting in the Reporting Person earning 3,396 RSUs, which are reported in Table I.
The total amount of shares beneficially owned includes 1,156 shares held in an employee stock purchase plan account.
The Issuer awarded the Reporting Person 636 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2022, 2023, 2024 and 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
The Issuer awarded the Reporting Person 3,388 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 50% installments on each of February 20, 2024 and February 20, 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
The information in this report is based on a plan statement dated as of December 31, 2020.
The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2022, 2023, 2024 and 2025, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2021, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2023, 2024 and 2025, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 50%-200% of the amount reported depending on the level of performance achieved.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2021-02-19